CMS warns on wet AMD, cataract surgery billing; watch Lucentis shots, modifiers

Why This Topic Matters

It helps readers understand why CMS flagged certain ophthalmology billing areas and where compliance review may be warranted in Medicare Part B claims.

Article Sections

1. CMS alert and related OIG attention

   Introduces the CMS notice and its connection to prior OIG reports involving ophthalmology billing patterns. Summarizes the general Medicare Part B context and referenced guidance sources.

2. OIG findings and contractor coverage patterns

   Reviews the broader OIG reports and how contractor-specific limitations were applied across jurisdictions. Discusses the article’s comparison of utilization and denial trends over time.

3. Provider perspectives on wet AMD, cataracts, and modifiers

   Presents commentary from clinicians and industry representatives on possible reasons for the billing concerns. Covers general issues related to cataract surgery claims, procedural documentation, laterality, and modifier reporting.